Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Sales | 0 | 0 | 0 | 0 | 130 |
| Gross Profit | N/A | N/A | N/A | N/A | 130 |
| Operating Expenses | 6,784 | 6,280 | 6,207 | 6,392 | 5,695 |
| Operating Income | -6,784 | -6,280 | -6,207 | -6,392 | -5,565 |
| Interest Expense | 203 | 189 | 198 | 6 | 9 |
| Other Income | 631 | -422 | 3,087 | 1,803 | -888 |
| Pre-tax Income | -6,356 | -6,891 | -3,318 | -4,595 | -6,462 |
| Income Tax | N/A | 7 | N/A | N/A | N/A |
| Net Income Continuous | -6,356 | -6,898 | -3,336 | -4,595 | -6,462 |
| Minority Interests | N/A | N/A | N/A | -10 | -14 |
| Net Income | $-6,356 | $-6,898 | $-3,336 | $-4,585 | $-6,448 |
| EPS Basic Total Ops | -0.55 | -0.58 | -0.31 | -0.45 | -0.66 |
| EPS Basic Continuous Ops | -0.39 | -0.57 | -0.30 | -0.44 | -0.65 |
| EPS Diluted Total Ops | -0.55 | -0.58 | -0.31 | -0.45 | -0.66 |
| EPS Diluted Continuous Ops | -0.39 | -0.57 | -0.30 | -0.44 | -0.65 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.58 | -0.31 | -0.45 | -0.66 |
| EBITDA(a) | $-6,689 | $-6,198 | $-6,125 | $-6,376 | $-5,549 |